![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 21179-21188, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 10, 2001, and in revised form, March 27, 2002
The determinants for the formation of
multilayers upon compression of surfactant monolayers were investigated
by compressing films, beyond the squeeze-out plateau, to a surface
tension of 22 millinewtons/m. Atomic force microscopy was used
to visualize the topography of lipid films containing varying amounts
of native surfactant protein B (SP-B). These films were compared with
films containing synthetic peptides based on the N terminus of human SP-B: monomeric mSP-B-(1-25) or dimeric dSP-B-(1-25). The
formation of typical hexagonal network structures as well as the height of protrusions were shown to depend on the concentration of SP-B. Protrusions of bilayer height were formed from physiologically relevant
concentrations of 0.2-0.4 mol % (4.5-8.5 wt %) SP-B upwards. Much
higher concentrations of SP-B-(1-25) peptides were needed to obtain
network structures, and protrusion heights were not equal
to those found for films with native SP-B. A striking observation was
that while protrusions formed in films of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (DPPG) (80/20) had single bilayer thickness, those formed in
DPPC/1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (80/20) had various heights of multilayers, whereas those seen in
DPPC/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/DPPG (60/20/20) were mainly of bilayer height. For the first time direct observations by atomic force microscopy show (i) that a certain minimal
concentration of SP-B is required for the formation of layered
protrusions upon film compression, (ii) that protrusion height depends
on whether the phospholipids contain an unsaturated fatty acyl
chain, and (iii) that protrusion height also depends on whether
the unsaturated acyl chain is present in phosphatidylcholine or in phosphatidylglycerol.
Pulmonary surfactant is a mixture of lipids and proteins
synthesized and secreted into the alveolar fluid by the alveolar type
II epithelial cells. Its main function is to reduce the surface tension
at the alveolar air/liquid interface, thus preventing the alveoli from
collapsing at end-expiration and making breathing at minimal effort
possible. This is achieved by the formation of a surface-active film
that consists of a lipid monolayer highly enriched in
1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC)1 and bilayer or
multilayer structures ("surface-associated reservoir") closely
attached to the monolayer. From such multilayer structures surfactant
material can be readily incorporated into the monolayer film upon
inspiration. The existence of a layered film has recently been
visualized in vitro by atomic force and fluorescence light microscopy (1-3) and in vivo by electron microscopy (4).
Film compression during expiration might lead to a squeeze-out of
non-DPPC (5, 6), film expansion during inspiration to selective
adsorption of DPPC (4), or they might just lead to an alteration of
structure rather than a change in composition (1, 3, 7, 8).
Administration of exogenous surfactant is a successful strategy in
treating premature infants suffering from respiratory distress syndrome
(9). Moreover surfactant therapy is also considered promising for
adults with acute respiratory distress syndrome (10-12). Presently the
majority of clinically used surfactants is derived from animals. In an
effort to circumvent the possibility of zoonotic infections and to
reduce the considerable costs of surfactant production, the use of
surfactants containing artificial proteins and lipids is currently
under consideration. With respect to the proteins, the hydrophobic
surfactant protein B (SP-B) is known to fulfill a crucial role in the
lung since respiratory distress is always observed in SP-B-deficient
humans (13, 14) and in homozygous SP-B-knockout mice (15). SP-B is a
79-amino acid amphipathic protein active as an 18-kDa dimer (16) and has a net positive charge that is thought to be essential for its
interaction with negatively charged phospholipids such as phosphatidylglycerol (PG) (17-19). The SP-B amino acid sequence among
mammals has been highly conserved (20). Because of the importance of
SP-B for proper surfactant activity, synthetic peptides based on its
sequence have been developed: mSP-B-(1-25) is a monomeric synthetic
peptide based on the N-terminal segment of human SP-B, while
dSP-B-(1-25) is the dimeric form of mSP-B-(1-25) (Fig. 1). The
structure and surface activity of these peptides have been investigated
thoroughly both in vitro and in vivo. The
conformation of mSP-B-(1-25) was found to be Various established methods, among which is captive bubble
surfactometry, are available to obtain information on surfactant surface activity. In addition to these methods, growing interest has
recently emerged in atomic force microscopy (AFM) (29), which yields
information on surface topography, thereby providing new insight into
the action of surfactant proteins and lipids during the breathing
cycle. Although it has been found that upon compression material is
squeezed out of the monolayer to form protrusions connected to the
monolayer (1, 2), it is so far not clear which surfactant components
determine the size and height of the protrusions. Therefore, in this
study we used AFM to visualize the determinants for protrusion
formation. For this purpose, we investigated monolayer films containing
either bovine SP-B or an SP-B-(1-25) peptide in the fully saturated
lipid system DPPC/1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
(DPPG) (80/20, mol/mol) or in the partially unsaturated
mixtures
DPPC/1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (POPG) (80/20) or
DPPC/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/DPPG (60/20/20).
Materials--
DPPC, DPPG, POPC, and POPG were obtained from
Avanti Polar Lipids (Alabaster, AL); chloroform (CHCl3) and
methanol (MeOH) from Labscan (Dublin, Ireland) were high pressure
liquid chromatography grade.
Biochemical Assays--
Bovine SP-B obtained from lung lavage
was isolated and characterized according to standard procedures (30).
The protein concentration was determined by fluorescamine assay (31).
Concentrations of phospholipids were determined according to Rouser
et al. (32). The monomeric peptide mSP-B-(1-25) was
synthesized based on the N-terminal 25 amino acids of human SP-B with
Cys-11 substituted for Ala (26) (Fig. 1).
The dimeric version of the peptide, dSP-B-(1-25), was obtained by
linking two monomer peptides through their only remaining cysteine,
Cys-8 (23).
Surface Pressure-Area Diagrams--
Surface pressure-area curves
were obtained using a home-built Teflon trough with an operational area
of 630 cm2. Surface tension was measured with a platinum
Wilhelmy plate connected to a microbalance (Cahn2000, Ankersmit,
Oosterhout, The Netherlands). Films, composed of DPPC/DPPG (80/20,
molar percentages), DPPC/POPG (80/20), or DPPC/POPC/DPPG (60/20/20)
plus varying amounts of bovine SP-B or one of the SP-B-(1-25)
peptides, were formed by spreading aliquots in CHCl3/MeOH
(1/1, v/v) onto the water subphase at 20 ± 3 °C. Usually an
amount of 100 nmol of phospholipid was used for the preparation of a
film. After the solvent had been allowed to evaporate for at least 5 min, films were compressed at a rate of 13.8% of the operational
area/min (28.8 Å2/molecule of lipid·min) until film
leakage occurred (usually at a surface tension of 10-15 mN/m).
Repeated measurements gave identical diagrams.
Atomic Force Microscopy--
For Langmuir-Blodgett transfer,
films were prepared on a home-built Teflon trough with an operational
area of 66.5 cm2. Surface tension was measured as described
above. Before film spreading, a freshly cleaved mica sheet was dipped
vertically into a subphase of demineralized water at room temperature
(20 ± 3 °C). Films, having the same composition as described
for the surface pressure-area curves, were formed by spreading aliquots onto the subphase. Usually an amount of 50 nmol of phospholipid was
used for the preparation of a film. The films were compressed at a rate
of 8.6% of the operational area/min until a surface tension of 22 mN/m
was reached. Subsequently the films were transferred onto a disc of
mica (14 mm in diameter) at a rate of 2.0 mm/min at constant surface tension.
For AFM measurements, transferred films were mounted on the J-type
scanner (150- × 150-µm scan range) of a Nanoscope III Multimode microscope (Digital Instruments, Santa Barbara, CA) operating in
contact mode in air. Scanning was performed using oxide-sharpened Si3N4 tips with a spring constant of 0.12 N/m.
The force with which the tip scanned the sample was set such that it
was as small as possible while the image was stable and clear, which
was usually at a force of 15 nN. Samples were checked for possible
tip-induced deformation by zooming out after a region had been scanned.
Since scanning in tapping mode did not give better images compared with those obtained in contact mode, we used contact mode because of its
ease of handling.
Statistics--
The computer program SPSS, version 9.0 (SPSS
Inc., Chicago, IL) was used for statistical analysis by analysis of
variance with Bonferroni's post-hoc test. Differences were considered
significant at p < 0.05.
Pressure-area isotherms were recorded to obtain information about
the surface tension at which protrusion formation occurred. Lipid/protein monolayers were compressed by movement of a barrier in a
Langmuir-Wilhelmy trough, which leads to a decrease in the area
available to the film. Consequently film surface pressure ( Lipid/protein films, compressed to the desired surface tension, were
deposited on mica, and the topography was subsequently visualized by
atomic force microscopy. Fig. 3 shows the
effect of surface tension on film structure using films of
DPPC/DPPG/SP-B (80/20/4, mol/mol/mol). Films deposited at
Multilayer Formation upon Compression of Surfactant Monolayers
Depends on Protein Concentration as Well as Lipid Composition
AN ATOMIC FORCE MICROSCOPY STUDY*
§,
**,
,

, and
§§
Department of Biochemistry and Cell Biology
and 
Department of the Science of Food of
Animal Origin, Graduate School of Animal Health, Faculty of Veterinary
Medicine, Utrecht University, PO Box 80176, 3508 TD Utrecht, The
Netherlands, the § Department of Anaesthesiology and
Critical Care Medicine, The Leopold-Franzens-University of Innsbruck,
A-6020 Innsbruck, Austria, ¶ Physical Chemistry of Interfaces,
Faculty of Chemistry, Utrecht University, 3584CH Utrecht, The
Netherlands, the
Department of Medicine, Division of Infectious
Diseases, UCLA, Los Angeles, California 90502, and the
** Department of Pediatrics, Division of Medical
Genetics, Harbor-UCLA Research and Education Institute, Torrance,
California 90502
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical (21, 22).
In vitro comparison of the surface activity of mSP-B-(1-25)
with that of dSP-B-(1-25) in a captive bubble surfactometer revealed
that both peptides reduced the surface tension, with the dimeric
peptide expressing better ability to lower surface tension than the
monomeric peptide (23). In vivo experiments showed that
SP-B-(1-25) peptides improved lung function in two animal models of
surfactant deficiency (24-27). With respect to the lipids (discussed
in Ref. 28), it has long been recognized that DPPC (40-50 wt % of the
surfactant lipid pool) is responsible for keeping the surface tension
near zero during expiration. Negatively charged PG (5-10 wt %) is
likely to interact with the positive charges of SP-B. Lipids with
unsaturated fatty acids are thought to be important for fluidizing the
surfactant film.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
Amino acid sequences of native SP-B and of
SP-B-derived synthetic peptides. The differences in amino acid
sequence between the various peptides are depicted in bold
font. X represents the rest of the amino acids of
native SP-B, which consists of 79 amino acids per monomer and is active
as a dimer.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) was
increased, and film surface tension (
) was lowered. The relationship
between
and
is given by the equation
= 72.5
, where 72.5 mN/m represents the surface tension of pure water at
21 °C. A typical pressure-area isotherm of pure lipid monolayers is
depicted in Fig. 2A. The
isotherm of DPPC/DPPG (80/20) shows phase behavior similar to that of
pure DPPC. When bovine SP-B was added to DPPC/DPPG (Fig.
2B), two plateau regions were observed: the first at a
surface pressure of ~23 mN/m and a second one, which was much more
pronounced, at
= 40 mN/m. These plateaus were seen most
clearly at higher protein concentrations and are in line with data
found for porcine SP-B (2). For monolayers containing 4 mol % SP-B the
squeeze-out plateau was elongated, and the monolayer could be
compressed to very low areas, indicating massive squeeze-out. No
additional plateaus were observed above
= 48 mN/m until onset
of film collapse (at approximately
= 59 mN/m in our
experimental setup), indicating that no extra squeeze-out occurred. For
mSP-B-(1-25)-containing monolayers, isotherms of films with 2 mol % or less peptide were identical to isotherms of DPPC/DPPG (Fig.
2C). Furthermore, at increasing peptide concentrations no
plateau like that observed at
= 40 mN/m for bovine SP-B was seen, but instead a region with a decreased slope was observed between
surface pressures of 8 and 32 mN/m, comparable to the first faint
plateau observed for bovine SP-B. The region with decreased slope was
most clearly visible for monolayers containing as much as 20 mol % peptide. If protrusion formation occurs, it can be expected to be in
this region. A similar region with decreased slope was seen for
dSP-B-(1-25) peptide-containing monolayers (Fig. 2D). From
Fig. 2 it is apparent that the compressibility of bovine
SP-B-containing monolayers is considerably higher than that of
monolayers containing SP-B-(1-25) peptides at the same concentration.
Since squeeze-out had fully occurred above a surface tension of 24 mN/m
(i.e. below a surface pressure of 48 mN/m), determinants for
protrusion formation were studied using monolayers compressed beyond
this plateau to a surface tension of 22 mN/m.

View larger version (22K):
[in a new window]
Fig. 2.
Pressure-area isotherms of DPPC/DPPG films
with and without native SP-B or SP-B-(1-25) peptide. Compression
isotherms of monolayers containing DPPC, DPPG, or DPPC/DPPG (80/20,
mol/mol) (A) or DPPC/DPPG (80/20) plus 0.02-4 mol % bovine
SP-B (B), 2-20 mol % mSP-B-(1-25) (C), or
2-20 mol % dSP-B-(1-25) (D) on a water subphase at
21 °C. The squeeze-out plateaus observed for bovine SP-B are
indicated by arrows (B).
= 62 mN/m, i.e. when squeeze-out has not yet occurred, showed
brighter islands (i.e. having a higher surface) surrounded
by darker (i.e. lower) regions (Fig. 3A).
According to other AFM studies (2, 3), the bright islands at this
surface tension correspond to liquid-condensed phase, while the dark
regions consist of liquid-expanded phase. The liquid-condensed domains
showed dark spots (readily seen at higher magnification, Fig.
3B), probably consisting of trapped liquid-expanded phase.
Upon compression of the monolayer (i.e. decreasing the
surface tension) the amount of liquid-condensed phase was increased
(Fig. 3C). The difference in height between both lipid
phases was found to be 1.2 ± 0.1 nm, which is similar to that
found by others (2, 3). Film topography altered dramatically when films
were compressed through the second plateau region of the isotherm to a
surface tension of 22 mN/m (Fig. 3D). At this surface
tension protrusions were formed that appeared as bright mountains among
dark valleys consisting of monolayer. The height of the protrusions was
4.1 ± 1.1 nm. It has been shown for the same lipid/protein
mixture that while the protrusions consist of proteins as well as
lipids in liquid-expanded phase, the lipid monolayer is in
liquid-condensed phase (2).

View larger version (119K):
[in a new window]
Fig. 3.
AFM topography of DPPC/DPPG films containing
native SP-B compressed to varying surface tensions. Films of
DPPC/DPPG/bovine SP-B (80/20/4, molar percentages) were transferred
onto mica at
= 62 mN/m (scan area = 10 × 10 µm in
A and 2 × 2 µm in B),
= 42 mN/m
(C) (scan area = 10 × 10 µm), and
= 22 mN/m (D) (scan area = 10 × 10 µm).
To learn more about the origin and development of the protrusions, we
made a concentration curve of bovine SP-B in DPPC/DPPG (80/20) films
compressed to a surface tension of 22 mN/m (Figs. 4 and 5). Although indications for
protrusion formation were observed even at very low SP-B concentration
(0.02 mol %), protrusion height differed with statistical significance
through the concentration curve: at very low concentration (0.02 mol
%) heights were 0.5 ± 0.1 nm, at low to moderate concentration
(0.1-0.2 mol %) heights were 2.0 ± 0.9 nm overall, and at
moderate to high concentrations (0.4-8 mol %) heights were 4.1 ± 1.1 nm overall (see Table I for
protrusion heights of individual concentrations). Furthermore, upon
increasing the protein concentration the protrusion regions became
connected and started forming networks of small circular domains
(readily observed as white dots in Fig. 4E). The
typical hexagonal shape of the cells of the networks is best
seen at a physiologically relevant SP-B concentration of 0.2-0.4 mol
%. Although AFM determinations in the x and y
direction are not as accurate as in the z direction, widths
of samples scanned with the same tip can be roughly compared with each
other. Protrusions were found to be disc-like in shape with a typical
diameter of ~35 nm that did not change over the range of SP-B
concentrations studied. An interesting observation was the presence of
large circles of protruded material captured inside a hexagonal cell most clearly seen in films containing 0.2 mol % SP-B (Fig.
4C). The height of these protrusions was 0.7 ± 0.1 nm,
suggesting that they represent domains with different lipid
orientation. One can speculate that these large circles consist of
lipids with extended acyl chains, which have an increased height
compared with the lipids around the circles either because the
lipids around the circles have tilted chains or because they are in a
fluid state like the lipids in the networks. The large circles were not
observed at high protein concentrations (2-8 mol %, Fig. 5) at which
the monolayer domains were much smaller. Increasing the SP-B
concentration led to a higher amount of protruded material until the
monolayer had almost vanished, and mostly protruded material was seen
(Fig. 5, E and F).
Meanwhile the network structures lost their typical hexagonal
appearance. Importantly when films contained no protein or peptide,
protrusions were not observed upon compression to a surface tension of
22 mN/m (not shown).
|
|
|
AFM images of films containing SP-B-(1-25) peptides differed
dramatically from those containing bovine SP-B in the sense that (i)
much higher peptide concentrations were needed to obtain the same kind
of network structures and (ii) the height of the protrusions was
considerably lower than that found for the native protein. Interestingly monomeric mSP-B-(1-25) and dimeric dSP-B-(1-25) were
found to have similar film topography (compare Figs.
6 and 7). Although protrusions were
visible at 2 mol % SP-B-(1-25) peptides (Figs. 6A and
7A), the first indication for structured networks was seen
at a peptide concentration of 8 mol % (Figs. 6B and
7B). At an SP-B-(1-25) concentration as high as 20 mol %,
hexagonal structures comparable to those of 0.4 mol % bovine SP-B were
observed, although the size of the hexagonal cells were markedly larger in the case of dSP-B-(1-25) than in that of mSP-B-(1-25) or native SP-B (compare Fig. 7C with Figs. 6C and
4D). The overall height of the protrusions was 2.7 ± 1.3 nm for films containing 2 or 8 mol % mSP-B-(1-25) or 2 mol % dSP-B-(1-25); see Table I for protrusion heights at individual
concentrations. Surprisingly the protrusion height of films containing
20 mol % mSP-B-(1-25) was significantly lower than that found at
lower mSP-B-(1-25) concentrations and for films containing
dSP-B-(1-25). Films containing 8 or 20 mol % dSP-B-(1-25) had
overall protrusion heights of 3.5 ± 1.7 nm. Protrusion heights of
films containing the SP-B-(1-25) peptides were significantly lower
than those containing 0.4 mol % bovine SP-B except for films with high
concentrations (8 and 20 mol %) of dSP-B-(1-25). Finally the tendency
to form the large circles of protruded material inside the network, as
observed for 0.2 mol % bovine SP-B (Fig. 4C), was also seen
for films containing 20 mol % dSP-B-(1-25) (Fig.
7, C and D).
|
|
The influence of lipid unsaturation on film topography was investigated
by substituting DPPG by POPG. For these experiments, protein or peptide
concentrations used were those previously observed to give clear
network structures in the DPPC/DPPG (80/20) mixtures, i.e.
0.4 mol % bovine SP-B and 20 mol % SP-B-(1-25) peptides. Compression
isotherms (Fig. 8) clearly showed
squeeze-out plateaus at approximately
= 40 mN/m (
= 32 mN/m) for DPPC/POPG films containing either native SP-B or SP-B-(1-25)
peptide. Film appearance (Fig. 9) was similar for lipid mixtures
containing either saturated or unsaturated PG (compare Fig.
9, A-C, with Figs.
4D, 6C, and 7C). The size of the
hexagonal cells was again larger in the case of dSP-B-(1-25) than for
mSP-B-(1-25), albeit the difference was less extreme than in the fully
saturated lipid system. DPPC/POPG films containing low amounts of
peptides, like 2 mol % mSP-B-(1-25) or 1 mol % dSP-B-(1-25), did
not show network structures (Fig. 9, D and E). A
spectacular difference was found for the height of the protrusions:
whereas in the case of a fully saturated lipid system compressed
material always formed protrusions with a height of ~4 nm, the
exchange of DPPG for POPG resulted in the presence of protrusions of up
to 24 nm. This was found for bovine SP-B as well as the SP-B-(1-25)
peptides. Mostly protrusions of 4, 8, 12, 16, 20, and 24 nm were found.
Occasionally higher protrusions of up to 60 nm were seen.
|
|
In a subsequent set of experiments the topography of films consisting
of DPPC/POPC/DPPG (60/20/20, molar percentages) instead of DPPC/POPG
(80/20) was investigated. In this way it was studied whether the
increased height of the protrusions was dependent on the presence of
the unsaturated acyl chain in phosphatidylglycerol or could also be
brought about by an unsaturated acyl chain in an equal number of the
phosphatidylcholine molecules. Compression isotherms of DPPC/POPC/DPPG
films containing proteins or peptides (Fig.
10) did not show the pronounced
plateaus as observed for films of DPPC/POPG at the same protein or
peptide concentration (Fig. 8), although to some degree isotherm
flattening was observed, albeit at higher surface pressure (at
= 42 mN/m) than in the films of the other lipid mixtures.
DPPC/POPC/DPPG films containing 20 mol % SP-B-(1-25) peptides (Fig.
11) appeared different from those
formed in the two other lipid mixtures at the same peptide concentration but resembled films of lower peptide concentration. Moreover network structures were not visible in films with 20 mol % mSP-B-(1-25). Surprisingly it was found for films with 0.4 mol % bovine SP-B or 20 mol % SP-B-(1-25) peptides that the heights of the
protrusions formed were mainly 4.4 ± 0.7 nm, which is lower than
the heights found for films containing DPPC/POPG. Heights of 8-32 nm
were also observed, but this was less common and was seen only for
films containing bovine SP-B and dimeric peptide.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Surfactants based on synthetic peptides are of growing interest for clinical use because of their low risk of containing biohazardous contaminants and their relative ease of production. Before clinical application of artificial surfactant, detailed knowledge about biophysical activity of their synthetic peptides and lipids is required. Here we describe the effect of synthetic peptides based on the N-terminal 25 amino acids of human SP-B on the topography of supported DPPC/DPPG (80/20) films and compare it with the effect of bovine SP-B, which is present in a large number of commercially available surfactants. Moreover the effect of lipid acyl chain unsaturation and the effect of the nature of the phospholipid that contains an unsaturated acyl chain on the formation of multilayered surfactant protrusions were investigated using films with DPPC/POPG (80/20) or DPPC/POPC/DPPG (60/20/20) as lipid components. Our findings suggest that the molecular composition of mixed lipid/protein monolayers plays an important role in surfactant film topography.
Compression isotherms of monolayers of DPPC/DPPG (80/20) with
bovine SP-B (0.02-4 mol %) showed two squeeze-out plateaus of which
the plateau starting at
= 32 mN/m was broadened as protein concentration increased (Fig. 2). It should be noted that we define squeeze-out as exclusion of fluid lipid and protein from the monolayer into the surface-associated reservoir and not as exclusion out of
layered structures and into an aqueous subphase. AFM measurements showed that increasing concentrations of bovine SP-B in DPPC/DPPG films
resulted in the formation of more protrusions. At SP-B levels of
0.2-0.4 mol % the protrusions appeared as small disc-like domains that formed network structures, which is in agreement with results from
AFM studies in which porcine SP-B was used (2). Interestingly similar
SP-B concentrations were found to show optimal activity in
vitro as measured by captive bubble surfactometer (0.5-0.75 mol
%) (33, 34), spreading trough (0.2 mol %) (33), and lipid mixing
assays (0.2 mol %) (18, 35, 36). Moreover SP-B levels of
0.2-0.4 mol % are comparable to the amount of SP-B reported in
bronchoalveolar lavage fluid, ranging from 0.02 (33) to 0.9 mol % (37). Ultimately addition of more protein will stop leading to
formation of extra protrusions due to the fact that there is no more
lipid available. This probably occurs in films with more than 4 mol % SP-B.
The protrusion height in experiments with films containing DPPC/DPPG
(80/20) and a concentration of native SP-B
0.4 mol % was 4.0-4.3 nm
(Table I). This is lower than in AFM studies using porcine SP-B in
DPPC/DPPG (80/20) in which protrusions with a height of 6-7 nm after
film compression to a surface tension of 22 mN/m were reported (2).
Although the same lipid mixture and protein were used and although
contact mode AFM in air was used both in our study and in the study by
Krol et al. (2), subtle differences in film compression
rate, temperature, brand of microscope, and force of scanning may
result in differences in measured protrusion height. In another study
using contact mode AFM, compression of mSP-B-(1-25) in a lipid mixture
of DPPG/POPG (3/1), transferred at
= 18 mN/m, was found to
result in protrusions of 10-40 nm in steps of 5.0 nm (3). Furthermore,
x-ray diffraction determination of bilayer thickness showed heights of
3.7 (38) to 4.3 nm (39) for DPPC in fluid liquid crystalline state and 4.7 nm for DPPC in gel state (39). Since our observed heights were
found to be reproducible along the concentration curve from 0.4 mol % bovine SP-B upwards, we believe that the height of 4 nm represents the
dimensions of a protruded bilayer. Since protrusion heights of
2 nm
were found for SP-B concentrations of
0.2 mol %, these protrusions
are not made up of bilayers. This means that low amounts of protein
relative to lipid cannot induce and sustain protrusions of bilayers but
will probably partly reorient the lipids and lift them out of the
monolayer. The molecular organization of such protruded material is not
clear. Assuming that formation of a surface-associated surfactant
reservoir is an important quality, we suggest that surfactants to be
used for therapy containing SP-B as the sole protein should contain
more than 0.2 mol % protein to ensure sufficient reservoir formation.
Compression isotherms of DPPC/DPPG monolayers containing the peptides
mSP-B-(1-25) and dSP-B-(1-25) (Fig. 2, C and D)
did not have the pronounced squeeze-out plateau observed for bovine SP-B at
= 40 mN/m (Fig. 2B) even when they were
used at high concentrations but showed a region of decreased slope
comparable to the faint plateau of bovine SP-B observed at
= 25 mN/m. The absence of a plateau suggests that squeeze-out in
SP-B-(1-25) peptide-containing films took place in a different way
than in films with the native protein. The compressibility of DPPC/DPPG films containing native SP-B (Fig. 2A) was higher than that
observed for films containing SP-B-(1-25) peptides (Fig. 2,
C and D). This may reflect a more pronounced
fluidizing effect of full-length SP-B compared with SP-B-(1-25)
peptides. Alternatively it could mean that native SP-B is better able
to stack the lipids in multilayers since dimeric SP-B is presumably
able to bind to the faces of two adjacent bilayers. This observation
was confirmed by AFM measurement that showed that much higher
SP-B-(1-25) peptide concentrations were needed to form structures
similar to those seen with native SP-B. Furthermore the height of the
protrusions was significantly smaller than that obtained with native
SP-B except when high concentrations (8 and 20 mol %) of dimeric
peptide were included in the film. From this we conclude that, although
SP-B-(1-25) peptides are able to form network structures, they are not
as effective in doing so as is native SP-B. There are differences in
size between native SP-B and the SP-B-(1-25) peptides, the latter
being less positively charged than the native protein. Since a number
of studies have shown that SP-B specifically interacts with negatively charged PG (17-19, 36), the SP-B-(1-25) peptides probably have less
interaction with their surrounding lipids than does native SP-B. In
addition to this, native (dimeric) SP-B may be folded differently than
monomeric and dimeric peptide. These differences between native SP-B
and its analogs probably contribute to the differences in behavior
observed on the surface balance and by AFM.
Interestingly structures observed for films of DPPC/DPPG (80/20) containing mSP-B-(1-25) peptides and those containing dSP-B-(1-25) of roughly the same weight percent (i.e. at roughly the same amount of N termini) were not the same (compare for instance 20 mol % mSP-B-(1-25) (Fig. 6C) with 8 mol % dSP-B-(1-25) (Fig. 7B)). Similar structures for mSP-B-(1-25) and dSP-B-(1-25) were only observed when compared at equimolar peptide concentrations both in films of DPPC/DPPG (compare Fig. 6 with Fig. 7) and in films of DPPC/POPG (Fig. 9, compare B with C). This indicates that dimerization of mSP-B-(1-25) does not result in an increased tendency to form protrusions. However, in DPPC/POPC/DPPG films the dimeric peptide did show a higher tendency to form protrusion networks than did the monomeric peptide (Fig. 11, compare B with C). We have no explanation for this observation.
We found that the presence of unsaturated lipid acyl chains resulted in formation of multilayered structures. Multilayers were previously observed in studies using electron microscopy (4, 40). These findings are in accordance with a recent AFM study, using monomeric SP-B-(1-25) in DPPG/POPG (3/1) (3), in which multilayered structures were reported as well. Presumably unsaturated lipids are able to easily form curved protrusions during surface compression because of their fluid and flexible character, while mixtures containing only saturated lipids (e.g. DPPC/DPPG) will be tightly packed and resist squeeze-out into protrusions. It has been shown in a number of studies that SP-B specifically interacts with PG (17-19, 36, 41), and this interaction appears to be important for surfactant function (17, 41). The high number of multilayered protrusions found in DPPC/POPG lipid mixtures compared with the single bilayer protrusions found in DPPC/POPC/DPPG suggests that SP-B preferentially interacts with POPG rather than with POPC or DPPG.
We conclude (i) that proteins are required to form protrusions of
material that is squeezed out of the surfactant monolayer upon
compression and that protrusions of bilayer height are formed at a
physiologically relevant concentration of 0.4 mol % SP-B, (ii) that
peptides based on the first 25 amino acids of the N terminus of SP-B
are also able to induce protrusion formation but only at much higher
concentrations, and (iii) that determinants for protrusion height are
lipid unsaturation as well as lipid head group since, in the presence
of unsaturated lipid, protrusions of multiples of bilayers are found to
be formed most clearly in the presence of POPG. Assuming that
clinically successful surfactant must be able to form
surface-associated reservoir, it will have to contain sufficient
amounts of protrusion-inducing protein or peptide and phospholipids.
Synthetic SP-B-(1-25)-based surfactants to be used for therapy will
therefore have to contain, in addition to DPPC, a high concentration of
SP-B-(1-25) peptides as well as unsaturated phospholipids,
preferentially unsaturated PG.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. Anja ten Brinke for inspiring discussions about this work.
| |
FOOTNOTES |
|---|
* This work was supported by the Fonds zur Förderung der Wissenschaftlichen Forschung FWF (to G. P. and R. V. D.) and the European Commission (Contract No. QLK2-CT-2000-00325 to J. J. B. and H. P. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§§ To whom correspondence should be addressed. Fax: 31-30-2535492; E-mail: J.J.Batenburg@vet.uu.nl.
Published, JBC Papers in Press, March 28, 2002, DOI 10.1074/jbc.M111758200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine;
AFM, atomic
force microscopy;
DPPG, 1,2-dipalmitoyl-sn-glycero-3-(phospho-rac-(1-glycerol));
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine;
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol));
SP-B, surfactant protein B;
mSP-B, monomeric SP-B;
dSP-B, dimeric SP-B;
, surface tension;
, surface pressure;
N, newtons;
PG, phosphatidylglycerol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Amrein, M., von Nahmen, A., and Sieber, M. (1997) Eur. Biophys. J. 26, 349-357[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Krol, S.,
Ross, M.,
Sieber, M.,
Kunneke, S.,
Galla, H.-J.,
and Janshoff, A.
(2000)
Biophys. J.
79,
904-918 |
| 3. |
Takamoto, D. Y.,
Lipp, M. M.,
von Nahmen, A.,
Lee, K. Y.,
Waring, A. J.,
and Zasadzinski, J. A.
(2001)
Biophys. J.
81,
153-169 |
| 4. | Schürch, S., Qanbar, R., Bachofen, H., and Possmayer, F. (1995) Biol. Neonate 67 Suppl. 1, 61-76 |
| 5. | Bangham, A. D., Morley, C. J., and Phillips, M. C. (1979) Biochim. Biophys. Acta 573, 552-556[Medline] [Order article via Infotrieve] |
| 6. | Clements, J. A. (1977) Am. Rev. Respir. Dis. 115, 67-71[Medline] [Order article via Infotrieve] |
| 7. |
Crane, J. M.,
and Hall, S. B.
(2001)
Biophys. J.
80,
1863-1872 |
| 8. | Lipp, M. M., Lee, K. Y. C., Takamoto, D. Y., Zasadinski, J. A., and Waring, A. J. (1998) Phys. Rev. Lett. 81, 1650-1653[CrossRef] |
| 9. | Robertson, B., and Halliday, H. L. (1998) Biochim. Biophys. Acta 1408, 346-361[Medline] [Order article via Infotrieve] |
| 10. | Walmrath, D., Günther, A., Ghofrani, H. A., Schermuly, R., Schneider, T., Grimminger, F., and Seeger, W. (1996) Am. J. Respir. Crit. Care Med. 154, 57-62[Abstract] |
| 11. | Gregory, T. J., Steinberg, K. P., Spragg, R. G., Gadek, J. E., Hyers, T. M., Longmore, W. J., Moxley, M. A., Cai, G. Z., Hite, R. D., Smith, R. M., Hudson, L. D., Crim, C., Newton, P., Mitchell, B. R., and Gold, A. J. (1997) Am. J. Respir. Crit. Care Med. 155, 1309-1315[Abstract] |
| 12. | Seeger, W., Günther, A., and Walmrath, D. (2000) Appl. Cardiopulm. Pathophysiol. 9, 295-297 |
| 13. | Tredano, M., van Elburg, R. M., Kaspers, A. G., Zimmermann, L. J., Houdayer, C., Aymard, P., Hull, W. M., Whitsett, J. A., Elion, J., Griese, M., and Bahuau, M. (1999) Hum. Mutat. 14, 502-509[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Nogee, L. M., Garnier, G., Dietz, H. C., Singer, L., Murphy, A. M., deMello, D. E., and Colten, H. R. (1994) J. Clin. Investig. 93, 1860-1863 |
| 15. | Weaver, T. E., and Beck, D. C. (1999) Biol. Neonate 76 Suppl. 1, 15-18 |
| 16. |
Hawgood, S.,
Benson, B. J.,
Schilling, J.,
Damm, D.,
Clements, J. A.,
and White, R. T.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
66-70 |
| 17. | Yu, S. H., and Possmayer, F. (1992) Biochim. Biophys. Acta 1126, 26-34[Medline] [Order article via Infotrieve] |
| 18. | Pérez-Gil, J., Casals, C., and Marsh, D. (1995) Biochemistry 34, 3964-3971[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Baatz, J. E., Elledge, B., and Whitsett, J. A. (1990) Biochemistry 29, 6714-6720[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Haagsman, H. P., and Diemel, R. V. (2001) Comp. Biochem. Physiol. A 129, 91-108 |
| 21. | Gordon, L. M., Lee, K. Y., Lipp, M. M., Zasadzinski, J. A., Walther, F. J., Sherman, M. A., and Waring, A. J. (2000) J. Pept. Res. 55, 330-347[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Gordon, L. M., Horvath, S., Longo, M. L., Zasadzinski, J. A., Taeusch, H. W., Faull, K., Leung, C., and Waring, A. J. (1996) Protein Sci. 5, 1662-1675[Abstract] |
| 23. |
Veldhuizen, E. J. A.,
Waring, A. J.,
Walther, F. J.,
Batenburg, J. J.,
van Golde, L. M. G.,
and Haagsman, H. P.
(2000)
Biophys. J.
79,
377-384 |
| 24. | Gupta, M., Hernandez-Juviel, J. M., Waring, A. J., Bruni, R., and Walther, F. J. (2000) Am. J. Respir. Crit. Care Med. 161, A656 |
| 25. | Walther, F. J., Hernandez-Juviel, J. M., Gupta, M., Bruni, R., and Waring, A. J. (2000) Am. J. Respir. Crit. Care Med. 161, A656 |
| 26. | Waring, A. J., Taeusch, H. W., Bruni, R., Amirkhanian, J. D., Fan, B. R., Stevens, R., and Young, J. (1989) Pept. Res. 2, 308-313[Medline] [Order article via Infotrieve] |
| 27. | Gupta, M., Hernandez-Juviel, J. M., Waring, A. J., Bruni, R., and Walther, F. J. (2000) Eur. Respir. J. 16, 1129-1133[Abstract] |
| 28. | Veldhuizen, R. A., Nag, K., Orgeig, S., and Possmayer, F. (1998) Biochim. Biophys. Acta 1408, 90-108[Medline] [Order article via Infotrieve] |
| 29. | Binnig, G., Quate, C. F., and Gerber, C. (1986) Phys. Rev. Lett. 56, 930-933[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Oosterlaken-Dijksterhuis, M. A., Haagsman, H. P., van Golde, L. M. G., and Demel, R. A. (1991) Biochemistry 30, 10965-10971[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Böhlen, P., Stein, S., Dairman, W., and Udenfriend, S. (1973) Arch. Biochem. Biophys. 155, 213-220[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Rouser, G., Fleischer, S., and Yamamoto, A. (1970) Lipids 5, 494-496[Medline] [Order article via Infotrieve] |
| 33. | Diemel, R. V., Bader, D., Walch, M., Hotter, B., van Golde, L. M. G., Amann, A., Haagsman, H. P., and Putz, G. (2001) Arch. Biochem. Biophys. 385, 338-347[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Veldhuizen, E. J. A., Diemel, R. V., Putz, G., van Golde, L. M. G., Batenburg, J. J., and Haagsman, H. P. (2001) Chem. Phys. Lipids 110, 47-55[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Oosterlaken-Dijksterhuis, M. A., van Eijk, M., van Golde, L. M. G., and Haagsman, H. P. (1992) Biochim. Biophys. Acta 1110, 45-50[Medline] [Order article via Infotrieve] |
| 36. | Creuwels, L. A. J. M., van Golde, L. M. G., and Haagsman, H. P. (1996) Biochim. Biophys. Acta 1285, 1-8[Medline] [Order article via Infotrieve] |
| 37. | Johansson, J., and Curstedt, T. (1997) Eur. J. Biochem. 244, 675-693[Medline] [Order article via Infotrieve] |
| 38. | Lewis, B. A., and Engelman, D. M. (1983) J. Mol. Biol. 166, 211-217[Medline] [Order article via Infotrieve] |
| 39. | Marsh, D. (1990) Handbook of Lipid Bilayers , CRC, Boca Raton, FL |
| 40. | Schürch, S., Green, F. H., and Bachofen, H. (1998) Biochim. Biophys. Acta 1408, 180-202[Medline] [Order article via Infotrieve] |
| 41. |
Rodriguez-Capote, K.,
Nag, K.,
Schürch, S.,
and Possmayer, F.
(2001)
Am. J. Physiol.
281,
L231-L242 |
This article has been cited by other articles:
![]() |
W. K. Fullagar, S. A. Holt, and I. R. Gentle Structure of SP-B/DPPC Mixed Films Studied by Neutron Reflectometry Biophys. J., November 15, 2008; 95(10): 4829 - 4836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Zuo, E. Keating, L. Zhao, S. M. Tadayyon, R. A. W. Veldhuizen, N. O. Petersen, and F. Possmayer Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films. I. Micro- and Nanostructures of Functional Pulmonary Surfactant Films and the Effect of SP-A Biophys. J., May 1, 2008; 94(9): 3549 - 3564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saleem, M. C. Meyer, D. Breitenstein, and H.-J. Galla The Surfactant Peptide KL4 in Lipid Monolayers: PHASE BEHAVIOR, TOPOGRAPHY, AND CHEMICAL DISTRIBUTION J. Biol. Chem., February 22, 2008; 283(8): 5195 - 5207. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Breitenstein, J. J. Batenburg, B. Hagenhoff, and H.-J. Galla Lipid Specificity of Surfactant Protein B Studied by Time-of-Flight Secondary Ion Mass Spectrometry Biophys. J., August 15, 2006; 91(4): 1347 - 1356. [Abstract] [Full Text] [PDF] |
||||